Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Lumos Pharma Inc (LUMO)  
$2.25 0.04 (1.75%) as of 4:30 Fri 5/31


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 8,290,000
Market Cap: 18.65(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.24 - $4.38
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Lumos Pharma is a clinical-stage biopharmaceutical company. Co. is engaged in developing its clinical program and focused on identifying, acquiring, developing, and commercialization products and new therapies for people with rare diseases. Co.'s pipeline is focused on the development of an orally administered small molecule, LUM-201, which is a growth hormone (GH) secretagogue, also called ibutamoren, for rare endocrine disorders where injectable recombinant human growth hormone is approved. Co.'s small-molecule product candidates, indoximod, NLG802 (a prodrug of indoximod) and NLG919 (a direct IDO1 enzymatic inhibitor) are indoleamine-2, 3-dioxygenase pathway inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 12,789
Total Buy Value $0 $0 $0 $96,371
Total People Bought 0 0 0 3
Total Buy Transactions 0 0 0 7
Total Shares Sold 2,214 2,652 6,059 10,074
Total Sell Value $6,144 $7,472 $18,391 $48,860
Total People Sold 1 1 1 1
Total Sell Transactions 1 2 3 6
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 303
  Page 6 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Langren Carl W. Chief Financial Officer   •       –      –    2019-01-04 4 D $1.55 $617 D/D (398) 20,425     -
   Vahanian Nicholas N. President   •       –      –    2019-01-04 4 D $1.55 $4,070 D/D (2,626) 48,553     -
   Kennedy Eugene P. Chief Medical Officer   •       –      –    2019-01-04 4 D $1.55 $583 D/D (376) 13,516     -
   Link Charles J. Jr. Chairman of the Board and CEO   •       •      –    2019-01-02 4 D $1.66 $9,460 D/D (5,699) 256,707     -
   Langren Carl W. Chief Financial Officer   •       –      –    2019-01-02 4 D $1.66 $1,072 D/D (646) 20,823     -
   Vahanian Nicholas N. President   •       –      –    2019-01-02 4 D $1.66 $3,700 D/D (2,229) 51,179     -
   Link Charles J. Jr. Chairman of the Board and CEO   •       •      –    2018-12-12 4 OE $0.80 $2,051 D/D 2,564 262,406     -
   Langren Carl W. Chief Financial Officer   •       –      –    2018-12-12 4 OE $0.80 $2,051 D/D 2,564 21,469     -
   Henneman John B III Chief Administrative Officer   •       –      –    2018-10-01 4 D $2.28 $5,664 D/D (2,484) 55,052     -
   Talarico Ernest Iii Director   –       •      –    2018-07-10 4 S $4.82 $66,600 D/D (13,806) 32,223     -
   Talarico Ernest Iii Director   –       •      –    2018-07-10 4 OE $2.10 $28,993 D/D 13,806 46,029     -
   Kennedy Eugene P. Chief Medical Officer   •       –      –    2018-01-20 4 D $8.62 $733 D/D (85) 13,892     -
   Kennedy Eugene P. Chief Medical Officer   •       –      –    2018-01-04 4 D $10.06 $4,115 D/D (409) 13,977     -
   Henneman John B III EVP, Chief Financial Officer   •       –      –    2018-01-04 4 D $10.06 $13,309 D/D (1,323) 57,536     -
   Vahanian Nicholas N. President, Chief Medical Offic   •       –      –    2018-01-04 4 D $10.06 $26,750 D/D (2,659) 53,408     -
   Link Charles J. Jr. Chairman of the Board and CEO   •       •      –    2018-01-04 4 D $10.06 $55,742 D/D (5,541) 259,842     -
   Langren Carl W. Principal Accounting Officer   •       –      –    2018-01-04 4 D $10.06 $2,585 D/D (257) 18,905     -
   Wiley Brian Chief Commercial Officer   •       –      –    2018-01-04 4 D $10.06 $6,066 D/D (603) 18,150     -
   Henneman John B III EVP, Chief Financial Officer   •       –      –    2018-01-02 4 D $8.47 $1,389 D/D (164) 58,859     -
   Vahanian Nicholas N. President, Chief Medical Offic   •       –      –    2018-01-02 4 D $8.47 $32,745 D/D (3,866) 56,067     -
   Link Charles J. Jr. Chairman of the Board and CEO   •       •      –    2018-01-02 4 D $8.47 $75,713 D/D (8,939) 265,383     -
   Langren Carl W. Principal Accounting Officer   •       –      –    2018-01-02 4 D $8.47 $7,479 D/D (883) 19,162     -
   Wiley Brian Chief Commercial Officer   •       –      –    2018-01-02 4 D $8.47 $10,477 D/D (1,237) 18,753     -
   Langren Carl W. Principal Accounting Officer   •       –      –    2017-11-21 4 S $9.05 $20,172 D/D (2,229) 19,666     -
   Langren Carl W. Principal Accounting Officer   •       –      –    2017-11-21 4 OE $2.10 $19,998 D/D 9,523 21,895     -
  303 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us